For global pharmaceutical executives and investors tracking China’s ascent in innovative drug development, the scale of Chi-Med’s planned commercial buildout…
For global pharmaceutical executives and investors tracking China’s ascent in innovative drug development, the scale of Chi-Med’s planned commercial buildout signals confidence not just in…
China has crossed a significant ethical and clinical threshold in brain-computer interface technology. The move signals a determined push to convert frontier neuroscience into measurable…
As artificial intelligence drives the next wave of industrial transformation, the human cost of automation is becoming impossible to ignore — even for the world’s…
For global investors and automakers watching the electric vehicle supply chain, CATL’s move signals a strategic shift: the world’s largest battery maker is no longer…
For global professionals tracking China’s biotech trajectory, the Hong Kong-Singapore comparison is a revealing lens on how policy, infrastructure, and regional integration shape a sector’s…
China’s capital is not just talking about becoming a global science hub; it has laid out a concrete, multi-trillion-yuan plan to dominate the next generation…
China’s first offshore carbon capture and injection project is not just an environmental milestone; it is a strategic move to unlock hard-to-reach natural gas reserves…
The competition is no longer just about better algorithms. It is about which nation, or which bloc, will set the standards, own the infrastructure, and…
For biotech and technology companies that rely on offshore structures for financing and listing, China’s more stringent regulatory posture signals a structural shift in how…
China’s push for chip self-reliance takes a practical turn as Alibaba launches an open-source processor designed for the next wave of artificial intelligence. Alibaba Group…
No products in the cart.
